# Petco Health & Wellness Company, Inc.: overview

WOOF · Nasdaq · CIK 1826470 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/woof.md) · [Financials](/companies/woof/financials.md) · [Filings](/companies/woof/filings.md) · [Insiders](/companies/woof/insiders.md)

Latest reported revenue: [$1.49bn](/filings/0001193125-26-383639.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Sep 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-383639).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,511](/filings/0001193125-25-309620.md) | [1,552 d](/filings/0001193125-26-106114.md) | [1,493](/filings/0001193125-26-259944.md) | [1,489](/filings/0001193125-26-383639.md) | [1,464](/filings/0001193125-25-309620.md) | [1,515 d](/filings/0001193125-26-106114.md) | [1,497](/filings/0001193125-26-259944.md) | [1,489](/filings/0001193125-26-383639.md) |
| Gross margin | % | [38.1%](/filings/0001193125-25-309620.md) | [38.0% d](/filings/0001193125-26-106114.md) | [38.2%](/filings/0001193125-26-259944.md) | [39.3%](/filings/0001193125-26-383639.md) | [38.9%](/filings/0001193125-25-309620.md) | [38.3% d](/filings/0001193125-26-106114.md) | [38.4%](/filings/0001193125-26-259944.md) | [39.7%](/filings/0001193125-26-383639.md) |
| Operating margin | % | [0.3%](/filings/0001193125-25-309620.md) | [1.1% d](/filings/0001193125-26-106114.md) | [1.1%](/filings/0001193125-26-259944.md) | [2.9%](/filings/0001193125-26-383639.md) | [2.0%](/filings/0001193125-25-309620.md) | [2.1% d](/filings/0001193125-26-106114.md) | [1.6%](/filings/0001193125-26-259944.md) | [3.2%](/filings/0001193125-26-383639.md) |
| Net margin | % | [(1.1%)](/filings/0001193125-25-309620.md) | [(0.9%) d](/filings/0001193125-26-106114.md) | [(0.8%)](/filings/0001193125-26-259944.md) | [0.9%](/filings/0001193125-26-383639.md) | [0.6%](/filings/0001193125-25-309620.md) | [(0.2%) d](/filings/0001193125-26-106114.md) | [(1.0%)](/filings/0001193125-26-259944.md) | [2.6%](/filings/0001193125-26-383639.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001193125-25-309620.md) | not reported | [(0.04)](/filings/0001193125-26-259944.md) | [0.05](/filings/0001193125-26-383639.md) | [0.03](/filings/0001193125-25-309620.md) | not reported | [(0.05)](/filings/0001193125-26-259944.md) | [0.13](/filings/0001193125-26-383639.md) |
| Free cash flow | $m | [(10.3) d](/filings/0001193125-25-309620.md) | [59.0 d](/filings/0001193125-26-106114.md) | [(43.9)](/filings/0001193125-26-259944.md) | [53.8 d](/filings/0001193125-26-383639.md) | [60.6 d](/filings/0001193125-25-309620.md) | [116 d](/filings/0001193125-26-106114.md) | [(69.1)](/filings/0001193125-26-259944.md) | [130 d](/filings/0001193125-26-383639.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,807](/filings/0000950170-24-040516.md) | [6,036](/filings/0000950170-25-047693.md) | [6,255](/filings/0001193125-26-106114.md) | [6,116](/filings/0001193125-26-106114.md) | [5,961](/filings/0001193125-26-106114.md) |
| Gross margin | % | [41.8%](/filings/0000950170-24-040516.md) | [40.2%](/filings/0000950170-25-047693.md) | [37.6%](/filings/0001193125-26-106114.md) | [38.0%](/filings/0001193125-26-106114.md) | [38.7%](/filings/0001193125-26-106114.md) |
| Operating margin | % | [4.6%](/filings/0000950170-24-040516.md) | [3.7%](/filings/0000950170-25-047693.md) | [(18.9%)](/filings/0001193125-26-106114.md) | [0.1%](/filings/0001193125-26-106114.md) | [2.0%](/filings/0001193125-26-106114.md) |
| Net margin | % | [2.8%](/filings/0000950170-24-040516.md) | [1.5%](/filings/0000950170-25-047693.md) | [(20.5%)](/filings/0001193125-26-106114.md) | [(1.7%)](/filings/0001193125-26-106114.md) | [0.2%](/filings/0001193125-26-106114.md) |
| Diluted EPS | $ per share | [0.62](/filings/0000950170-24-040516.md) | [0.34](/filings/0000950170-25-047693.md) | [(4.78)](/filings/0001193125-26-106114.md) | [(0.37)](/filings/0001193125-26-106114.md) | [0.03](/filings/0001193125-26-106114.md) |
| Free cash flow | $m | [119](/filings/0000950170-24-040516.md) | [68.0](/filings/0000950170-25-047693.md) | [(9.9)](/filings/0001193125-26-106114.md) | [49.7](/filings/0001193125-26-106114.md) | [187](/filings/0001193125-26-106114.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/woof/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CVC Management Holdings II Ltd.](/funds/2023131.md) | 2026-06-30 | $396.9m | 145,924,140 |  | Unchanged |
| [CANADA PENSION PLAN INVESTMENT BOARD](/funds/1283718.md) | 2026-06-30 | $162.6m | 59,765,368 |  | Unchanged |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $30.1m | 11,072,709 |  | Added +961,648 |
| [Long Focus Capital Management, LLC](/funds/1602716.md) | 2026-06-30 | $22.8m | 8,371,050 |  | Added +360,999 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $22.0m | 8,082,129 |  | Reduced −131,866 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $15.2m | 5,577,176 |  | Reduced −392,398 |
| [Holocene Advisors, LP](/funds/1700574.md) | 2026-06-30 | $13.3m | 4,904,000 |  | Reduced −858,654 |
| [Cresset Asset Management, LLC](/funds/1761013.md) | 2026-06-30 | $10.5m | 3,865,368 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.5m | 3,842,365 |  | Added +359,013 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $10.4m | 3,822,806 |  | Reduced −316,175 |

## Recent filings

[All 526 filings](/companies/woof/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-04 | 20:05 ET | [10-Q](/filings/0001193125-26-383639.md) | Quarterly report, period 2026-08-01 | 0001193125-26-383639 |
| 2026-09-02 | 20:10 ET | [8-K](/filings/0001193125-26-380189.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-380189 |
| 2026-08-03 | 12:15 ET | [8-K](/filings/0001193125-26-329596.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-329596 |
| 2026-07-17 | 20:45 ET | [8-K](/filings/0001193125-26-307934.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-307934 |
| 2026-07-01 | 20:05 ET | [8-K](/filings/0001826470-26-000047.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001826470-26-000047 |
| 2026-06-05 | 21:18 ET | [10-Q](/filings/0001193125-26-259944.md) | Quarterly report, period 2026-05-02 | 0001193125-26-259944 |
| 2026-06-03 | 20:10 ET | [8-K](/filings/0001826470-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001826470-26-000045 |
| 2026-05-14 | 20:10 ET | [DEF 14A](/filings/0001826470-26-000040.md) | Proxy statement, period 2026-06-30 | 0001826470-26-000040 |
| 2026-03-13 | 20:06 ET | [10-K](/filings/0001193125-26-106114.md) | Annual report, period 2026-01-31 | 0001193125-26-106114 |
| 2026-03-11 | 20:10 ET | [8-K](/filings/0001193125-26-102144.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-102144 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001193125-26-106114.md), filed Mar 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1826470
- Tickers: WOOF
- Exchange: Nasdaq
- SIC code: 5990 Retail-Retail Stores, NEC
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.